Co-Diagnostics Announces Updated Third Quarter 2026 Earnings Release Date and Webcast
PR Newswire•05/11/2026•17:00 ET
0
Key Highlights
- ➤Co-Diagnostics (CODX) will release Q3 2026 financial results November 10 after market close
- ➤Earnings webcast and conference call scheduled for November 10 at 4:30 p.m. ET
- ➤Release moved up from previously announced November 12 date
Co-Diagnostics Announces Updated Third Quarter 2026 Earnings Release Date and Webcast PR Newswire
SALT LAKE CITY, Nov. 5, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it will release its third quarter 2026 financial results on Tuesday, November 10, 2026, after the market close, rather than the previously announced date of Thursday, November 12, 2026. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results.
Get started
Create a free account to read the full story.
